[1] Wu D,Gao Y,Qi Y,et al.Peptide-based cancer therapy:opportunity and challenge[J].Cancer Lett,2014,351(1):13-22.
[2] Strominger JL,Fridkis-Hareli M.Synthetic peptides and methods of use for autoimmune disease therapies[M].WO,2015.
[3] Bavec A.(Poly)peptide-based therapy for diabetes mellitus:Insulins versus incretins[J].Life Sci,2014,99(Suppl 1-2):7-13.
[4] Rosés C,Carbajo D,Sanclimens G,et al.Cell-penetrating γ-peptide/antimicrobial undecapeptide conjugates with anticancer activity[J].Tetrahedron,2012,68(23):4406-4412.
[5] Nguyen AD,Herzog H,Sainsbury A.Neuropeptide Y and peptide YY:important regulators of energy metabolism[J].Current Opinion in Endocrinology Diabetes & Obesity,2011,18(1):56-60.
[6] Saido TC.Metabolism of amyloid β peptide and pathogenesis of Alzheimer's disease[J].Proceedings of the Japan Academy Ser B Physical & Biological Sciences,2013,89(7):321-339.
[7] Celik O,Aydin S,Celik N,et al.Peptides:basic determinants of reproductive functions[J].Peptides,2015,72:34-43.
[8] Cheng TY,Chen MH,Chang WH,et al.Neural stem cells encapsulated in a functionalized self-assembling peptide hydrogel for brain tissue engineering[J].Biomaterials,2013,34(8):2005-2016.
[9] Hillis G,Welsh P,Chalmers J,et al.The relative and combined ability of high sensitivity cardiac troponin T and N-terminal pro-BNP to predict cardiovascular events and death in patients with type 2 diabetes mellitus[J].Heart Lung & Circulation,2013,22(Suppl 1):S68.
[10] Anderson D,Anderson K,Chang CL,et al.A micropeptide encoded by a putative long noncoding RNA regulates muscle performance[J].Cell,2015,160(4):595-606.
[11] Nelson BR,Makarewich CA,Anderson DM,et al.A peptide encoded by a transcript annotated as long noncoding RNA enhances SERCA activity in muscle[J].Science,2016,351(6270):271-275.
[12] Lecker SH,Goldberg AL.Slowing muscle atrophy:putting the brakes on protein breakdown[J].Journal of Physiology,2003,545(Pt 3):729-729.
[13] Romere C,Duerrschmid C,Bournat J,et al.Asprosin,a fasting-induced glucogenic protein hormone[J].Cell,2016,165(3):1-14.
[14] Bomar MG,Galande AK.Modulation of the cannabinoid receptors by hemopressin peptides[J].Life Sci,2013,92(8-9):520-524.
[15] Masuyer G,Schwager SL,Sturrock ED,et al.Molecular recognition and regulation of human angiotensin-I converting enzyme (ACE) activity by natural inhibitory peptides[J].Scientific Reports,2012,2(10):95-95.
[16] Mantha AK,Monisha D,Giulio T,et al.Proteomic study of amyloid beta (25-35) peptide exposure to neuronal cells:Impact on APE1/Ref-1's protein-protein interaction[J].J Neurosci Res,2012,90(6):539-544.
[17] Maes M,Loyter A,Friedler A.Peptides that inhibit HIV-1 integrase by blocking its protein-protein interactions[J].Febs Journal,2012,279(16):2795-2809.
[18] King J,Haase-Pettingell C,Gossard D.Protein folding and misfolding[M].Springer,2012.
[19] Armon-Omer A,Levin A,Hayouka Z,et al.Correlation between shiftide activity and HIV-1 integrase inhibition by a peptide selected from a combinatorial library[J].Journal of Molecular Biology,2008,376(4):971-982.
[20] Tomai E,Butz K,Lohrey C,et al.Peptide aptamer-mediated inhibition of target proteins by sequestration into aggresomes[J].J Biol Chem,2006,281(30):21345-21352.
[21] Zhang YY,Zhou LM.Sirt3 inhibits hepatocellular carcinoma cell growth through reducing Mdm2-mediated p53 degradation[J].Biochemical & Biophysical Research Communications,2012,423(1):26-31.
[22] Piccinin S,Tonin E,Sessa S,et al.A "Twist box" code of p53 inactivation:twist box:p53 interaction promotes p53 degradation[J].Cancer Cell,2012,22(3):404-415.
[23] Tsomaia N.Peptide therapeutics:Targeting the undruggable space[J].European Journal of Medicinal Chemistry,2015,94:459-470.
[24] Wang L,Teng R,Di L,et al.PPARα and Sirt1 mediate erythropoietin action in increasing metabolic activity and browning of white adipocytes to protect against obesity and metabolic disorders[J].Diabetes,2013,62(12):4122-4131.
[25] Teng R,Gavrilova O,Suzuki N,et al.Disrupted erythropoietin signalling promotes obesity and alters hypothalamus proopiomelanocortin production[J].Nature Communications,2011,2(1):193-198.
[26] Liu Y,Luo B,Shi R,et al.Nonerythropoietic erythropoietin-derived peptide suppresses adipogenesis,inflammation,obesity and insulin resistance[J].Scientific Reports,2014,5:15134.
[27] Wren AM,Small CJ,Ward HL,et al.The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion[J].Endocrinology,2013,141(11):4325-4328.
[28] Aulinger BA,Bedorf A,Kutscherauer G,et al.Defining the role of GLP-1 in the enteroinsulinar axis in type 2 diabetes (T2D) utilizing DPP-4 inhibition and GLP-1-receptor blockade[J].Diabetes,2013,63(3):1079-1092.
[29] Toft-Nielsen M,Madsbad S,Holst J.Determinants of the effectiveness of glucagon-like peptide-1 in type 2 diabetes[J].Journal of Clinical Endocrinology & Metabolism,2013,86(8):3853-3860.
[30] Vendrell J,El BR,Peral B,et al.Study of the potential association of adipose tissue GLP-1 receptor with obesity and insulin resistance[J].Endocrinology,2011,152(11):4072-4079.
[31] Tomas E,Stanojevic V,Habener JF.GLP-1-derived nonapeptide GLP-1 (28–36) amide targets to mitochondria and suppresses glucose production and oxidative stress in isolated mouse hepatocytes[J].Regulatory Peptides,2011,167(2):177-184.
[32] Tomas E,Stanojevic V,Mcmanus K,et al.GLP-1(32-36)amide pentapeptide increases basal energy expenditure and inhibits weight gain in obese mice[J].Diabetes,2015,64(7):2409-2419.
[33] Shameer K,Madan LL,Veeranna S,et al.PeptideMine - A webserver for the design of peptides for protein-peptide binding studies derived from protein-protein interactomes[J].Bmc Bioinformatics,2010,11(39):6588-6593.
[34] Camperi SA,Martínez-Ceron MC,Giudicessi SL,et al.Peptide affinity chromatography based on combinatorial strategies for protein purification[J].Methods in Molecular Biology,2014,1129:277-302.